A Feasibility Study for in Vivo Treatment Verification of IMRT Using Monte Carlo Dose Calculation and Deep Learning-based Modelling of EPID Detector Response
Overview
Affiliations
Background: This paper describes the development of a predicted electronic portal imaging device (EPID) transmission image (TI) using Monte Carlo (MC) and deep learning (DL). The measured and predicted TI were compared for two-dimensional in vivo radiotherapy treatment verification.
Methods: The plan CT was pre-processed and combined with solid water and then imported into PRIMO. The MC method was used to calculate the dose distribution of the combined CT. The U-net neural network-based deep learning model was trained to predict EPID TI based on the dose distribution of solid water calculated by PRIMO. The predicted TI was compared with the measured TI for two-dimensional in vivo treatment verification.
Results: The EPID TI of 1500 IMRT fields were acquired, among which 1200, 150, and 150 fields were used as the training set, the validation set, and the test set, respectively. A comparison of the predicted and measured TI was carried out using global gamma analyses of 3%/3 mm and 2%/2 mm (5% threshold) to validate the model's accuracy. The gamma pass rates were greater than 96.7% and 92.3%, and the mean gamma values were 0.21 and 0.32, respectively.
Conclusions: Our method facilitates the modelling process more easily and increases the calculation accuracy when using the MC algorithm to simulate the EPID response, and has potential to be used for in vivo treatment verification in the clinic.
A Novel Approach for Position Verification and Dose Calculation through Local MVCT Reconstruction.
Zhang J, Chen Z, Lei Y, Wen J Diagnostics (Basel). 2024; 14(5).
PMID: 38472954 PMC: 10931282. DOI: 10.3390/diagnostics14050482.
Zou Z, Gong C, Zeng L, Guan Y, Huang B, Yu X J Imaging Inform Med. 2024; 37(1):60-71.
PMID: 38343215 PMC: 10976903. DOI: 10.1007/s10278-023-00930-w.
AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA.
Dogan N, Mijnheer B, Padgett K, Nalichowski A, Wu C, Nyflot M Med Phys. 2023; 50(8):e865-e903.
PMID: 37384416 PMC: 11230298. DOI: 10.1002/mp.16536.
Artificial intelligence assists precision medicine in cancer treatment.
Liao J, Li X, Gan Y, Han S, Rong P, Wang W Front Oncol. 2023; 12:998222.
PMID: 36686757 PMC: 9846804. DOI: 10.3389/fonc.2022.998222.